Industry Research Reports
Home > Reports > Service & Software > Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-13
Pages: 136 Pages
Report ld: 4925233
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urine Drug Testing Service Market Size(US$)
CAGR 2025-2031
4.6%
Market Size,2031
USD 2,829
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,157 million
Market Forecast in 2031(Value)
US$ 2,829 million
CAGR
4.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Urine Drug Testing Service market is projected to grow from US$ 2085 million in 2024 to US$ 2829 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Urine Drug Testing Service refers to the process of analyzing a urine sample to detect the presence or absence of specific drugs or their metabolites, typically used for clinical, occupational, legal, or forensic purposes. This service is widely recognized as one of the most common and non-invasive drug testing methods due to its ease of sample collection, cost-effectiveness, and relatively long detection window for many substances. Urine drug testing can detect a wide range of substances, including cannabinoids, amphetamines, opioids, cocaine, benzodiazepines, and other prescription or illicit drugs. It is commonly employed in workplace drug screening programs, pre-employment checks, post-incident investigations, law enforcement, rehabilitation monitoring, and clinical diagnosis.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Urine Drug Testing Service leading manufacturers including Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health, Keystone Laboratories, Crystal Health, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Urine Drug Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Abbott
- Labcorp
- Quest Diagnostics
- Millennium Health
- Genesis Reference Labs
- Concentra
- DISA
- Medigold Health
- Keystone Laboratories
- Crystal Health
- MedTox
- Australian Clinical Labs
- Dominion Diagnostics
- Matrix Diagnostics
- Dorevitch Pathology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- On-site Testing
- Laboratory-based Testing
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Urine Drug Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Urine Drug Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Urine Drug Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 On-site Testing
1.2.3 Laboratory-based Testing
1.3 Market Segmentation by Application
1.3.1 Global Urine Drug Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urine Drug Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Urine Drug Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Urine Drug Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Urine Drug Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 On-site Testing Market Size by Players
3.3.2 Laboratory-based Testing Market Size by Players
3.4 Global Urine Drug Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Urine Drug Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Urine Drug Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Urine Drug Testing Service Market Size by Type (2020-2031)
6.4 North America Urine Drug Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Urine Drug Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Urine Drug Testing Service Market Size by Type (2020-2031)
7.4 Europe Urine Drug Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Urine Drug Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Urine Drug Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Urine Drug Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Urine Drug Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Urine Drug Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Urine Drug Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Urine Drug Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Urine Drug Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Urine Drug Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Urine Drug Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Urine Drug Testing Service Product Features and Attributes
11.1.4 Abbott Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Urine Drug Testing Service Revenue by Product in 2024
11.1.6 Abbott Urine Drug Testing Service Revenue by Application in 2024
11.1.7 Abbott Urine Drug Testing Service Revenue by Geographic Area in 2024
11.1.8 Abbott Urine Drug Testing Service SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Labcorp
11.2.1 Labcorp Corporation Information
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Urine Drug Testing Service Product Features and Attributes
11.2.4 Labcorp Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Labcorp Urine Drug Testing Service Revenue by Product in 2024
11.2.6 Labcorp Urine Drug Testing Service Revenue by Application in 2024
11.2.7 Labcorp Urine Drug Testing Service Revenue by Geographic Area in 2024
11.2.8 Labcorp Urine Drug Testing Service SWOT Analysis
11.2.9 Labcorp Recent Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Corporation Information
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Urine Drug Testing Service Product Features and Attributes
11.3.4 Quest Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Quest Diagnostics Urine Drug Testing Service Revenue by Product in 2024
11.3.6 Quest Diagnostics Urine Drug Testing Service Revenue by Application in 2024
11.3.7 Quest Diagnostics Urine Drug Testing Service Revenue by Geographic Area in 2024
11.3.8 Quest Diagnostics Urine Drug Testing Service SWOT Analysis
11.3.9 Quest Diagnostics Recent Developments
11.4 Millennium Health
11.4.1 Millennium Health Corporation Information
11.4.2 Millennium Health Business Overview
11.4.3 Millennium Health Urine Drug Testing Service Product Features and Attributes
11.4.4 Millennium Health Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Millennium Health Urine Drug Testing Service Revenue by Product in 2024
11.4.6 Millennium Health Urine Drug Testing Service Revenue by Application in 2024
11.4.7 Millennium Health Urine Drug Testing Service Revenue by Geographic Area in 2024
11.4.8 Millennium Health Urine Drug Testing Service SWOT Analysis
11.4.9 Millennium Health Recent Developments
11.5 Genesis Reference Labs
11.5.1 Genesis Reference Labs Corporation Information
11.5.2 Genesis Reference Labs Business Overview
11.5.3 Genesis Reference Labs Urine Drug Testing Service Product Features and Attributes
11.5.4 Genesis Reference Labs Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Genesis Reference Labs Urine Drug Testing Service Revenue by Product in 2024
11.5.6 Genesis Reference Labs Urine Drug Testing Service Revenue by Application in 2024
11.5.7 Genesis Reference Labs Urine Drug Testing Service Revenue by Geographic Area in 2024
11.5.8 Genesis Reference Labs Urine Drug Testing Service SWOT Analysis
11.5.9 Genesis Reference Labs Recent Developments
11.6 Concentra
11.6.1 Concentra Corporation Information
11.6.2 Concentra Business Overview
11.6.3 Concentra Urine Drug Testing Service Product Features and Attributes
11.6.4 Concentra Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Concentra Recent Developments
11.7 DISA
11.7.1 DISA Corporation Information
11.7.2 DISA Business Overview
11.7.3 DISA Urine Drug Testing Service Product Features and Attributes
11.7.4 DISA Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 DISA Recent Developments
11.8 Medigold Health
11.8.1 Medigold Health Corporation Information
11.8.2 Medigold Health Business Overview
11.8.3 Medigold Health Urine Drug Testing Service Product Features and Attributes
11.8.4 Medigold Health Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Medigold Health Recent Developments
11.9 Keystone Laboratories
11.9.1 Keystone Laboratories Corporation Information
11.9.2 Keystone Laboratories Business Overview
11.9.3 Keystone Laboratories Urine Drug Testing Service Product Features and Attributes
11.9.4 Keystone Laboratories Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Keystone Laboratories Recent Developments
11.10 Crystal Health
11.10.1 Crystal Health Corporation Information
11.10.2 Crystal Health Business Overview
11.10.3 Crystal Health Urine Drug Testing Service Product Features and Attributes
11.10.4 Crystal Health Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 MedTox
11.11.1 MedTox Corporation Information
11.11.2 MedTox Business Overview
11.11.3 MedTox Urine Drug Testing Service Product Features and Attributes
11.11.4 MedTox Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 MedTox Recent Developments
11.12 Australian Clinical Labs
11.12.1 Australian Clinical Labs Corporation Information
11.12.2 Australian Clinical Labs Business Overview
11.12.3 Australian Clinical Labs Urine Drug Testing Service Product Features and Attributes
11.12.4 Australian Clinical Labs Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Australian Clinical Labs Recent Developments
11.13 Dominion Diagnostics
11.13.1 Dominion Diagnostics Corporation Information
11.13.2 Dominion Diagnostics Business Overview
11.13.3 Dominion Diagnostics Urine Drug Testing Service Product Features and Attributes
11.13.4 Dominion Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 Dominion Diagnostics Recent Developments
11.14 Matrix Diagnostics
11.14.1 Matrix Diagnostics Corporation Information
11.14.2 Matrix Diagnostics Business Overview
11.14.3 Matrix Diagnostics Urine Drug Testing Service Product Features and Attributes
11.14.4 Matrix Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Matrix Diagnostics Recent Developments
11.15 Dorevitch Pathology
11.15.1 Dorevitch Pathology Corporation Information
11.15.2 Dorevitch Pathology Business Overview
11.15.3 Dorevitch Pathology Urine Drug Testing Service Product Features and Attributes
11.15.4 Dorevitch Pathology Urine Drug Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 Dorevitch Pathology Recent Developments
12 Urine Drug Testing ServiceIndustry Chain Analysis
12.1 Urine Drug Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Urine Drug Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Urine Drug Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Urine Drug Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Urine Drug Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Urine Drug Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Urine Drug Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Urine Drug Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Urine Drug Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Urine Drug Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Urine Drug Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urine Drug Testing Service as of 2024)
Table 11. Global Urine Drug Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Urine Drug Testing Service Companies Headquarters
Table 13. Global Urine Drug Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Urine Drug Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Urine Drug Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Urine Drug Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Urine Drug Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Urine Drug Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Urine Drug Testing Service Growth Accelerators and Market Barriers
Table 25. North America Urine Drug Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Urine Drug Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Urine Drug Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Urine Drug Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Urine Drug Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Urine Drug Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Urine Drug Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Urine Drug Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Urine Drug Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abbott Revenue Proportion by Product in 2024
Table 39. Abbott Revenue Proportion by Application in 2024
Table 40. Abbott Revenue Proportion by Geographic Area in 2024
Table 41. Abbott Urine Drug Testing Service SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. Labcorp Corporation Information
Table 44. Labcorp Description and Major Businesses
Table 45. Labcorp Product Features and Attributes
Table 46. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Labcorp Revenue Proportion by Product in 2024
Table 48. Labcorp Revenue Proportion by Application in 2024
Table 49. Labcorp Revenue Proportion by Geographic Area in 2024
Table 50. Labcorp Urine Drug Testing Service SWOT Analysis
Table 51. Labcorp Recent Developments
Table 52. Quest Diagnostics Corporation Information
Table 53. Quest Diagnostics Description and Major Businesses
Table 54. Quest Diagnostics Product Features and Attributes
Table 55. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Quest Diagnostics Revenue Proportion by Product in 2024
Table 57. Quest Diagnostics Revenue Proportion by Application in 2024
Table 58. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 59. Quest Diagnostics Urine Drug Testing Service SWOT Analysis
Table 60. Quest Diagnostics Recent Developments
Table 61. Millennium Health Corporation Information
Table 62. Millennium Health Description and Major Businesses
Table 63. Millennium Health Product Features and Attributes
Table 64. Millennium Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Millennium Health Revenue Proportion by Product in 2024
Table 66. Millennium Health Revenue Proportion by Application in 2024
Table 67. Millennium Health Revenue Proportion by Geographic Area in 2024
Table 68. Millennium Health Urine Drug Testing Service SWOT Analysis
Table 69. Millennium Health Recent Developments
Table 70. Genesis Reference Labs Corporation Information
Table 71. Genesis Reference Labs Description and Major Businesses
Table 72. Genesis Reference Labs Product Features and Attributes
Table 73. Genesis Reference Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Genesis Reference Labs Revenue Proportion by Product in 2024
Table 75. Genesis Reference Labs Revenue Proportion by Application in 2024
Table 76. Genesis Reference Labs Revenue Proportion by Geographic Area in 2024
Table 77. Genesis Reference Labs Urine Drug Testing Service SWOT Analysis
Table 78. Genesis Reference Labs Recent Developments
Table 79. Concentra Corporation Information
Table 80. Concentra Description and Major Businesses
Table 81. Concentra Product Features and Attributes
Table 82. Concentra Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Concentra Recent Developments
Table 84. DISA Corporation Information
Table 85. DISA Description and Major Businesses
Table 86. DISA Product Features and Attributes
Table 87. DISA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. DISA Recent Developments
Table 89. Medigold Health Corporation Information
Table 90. Medigold Health Description and Major Businesses
Table 91. Medigold Health Product Features and Attributes
Table 92. Medigold Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Medigold Health Recent Developments
Table 94. Keystone Laboratories Corporation Information
Table 95. Keystone Laboratories Description and Major Businesses
Table 96. Keystone Laboratories Product Features and Attributes
Table 97. Keystone Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Keystone Laboratories Recent Developments
Table 99. Crystal Health Corporation Information
Table 100. Crystal Health Description and Major Businesses
Table 101. Crystal Health Product Features and Attributes
Table 102. Crystal Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Crystal Health Recent Developments
Table 104. MedTox Corporation Information
Table 105. MedTox Description and Major Businesses
Table 106. MedTox Product Features and Attributes
Table 107. MedTox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. MedTox Recent Developments
Table 109. Australian Clinical Labs Corporation Information
Table 110. Australian Clinical Labs Description and Major Businesses
Table 111. Australian Clinical Labs Product Features and Attributes
Table 112. Australian Clinical Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Australian Clinical Labs Recent Developments
Table 114. Dominion Diagnostics Corporation Information
Table 115. Dominion Diagnostics Description and Major Businesses
Table 116. Dominion Diagnostics Product Features and Attributes
Table 117. Dominion Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Dominion Diagnostics Recent Developments
Table 119. Matrix Diagnostics Corporation Information
Table 120. Matrix Diagnostics Description and Major Businesses
Table 121. Matrix Diagnostics Product Features and Attributes
Table 122. Matrix Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Matrix Diagnostics Recent Developments
Table 124. Dorevitch Pathology Corporation Information
Table 125. Dorevitch Pathology Description and Major Businesses
Table 126. Dorevitch Pathology Product Features and Attributes
Table 127. Dorevitch Pathology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Dorevitch Pathology Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Urine Drug Testing Service Product Picture
Figure 2. Global Urine Drug Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. On-site Testing Product Picture
Figure 4. Laboratory-based Testing Product Picture
Figure 5. Global Urine Drug Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Urine Drug Testing Service Report Years Considered
Figure 10. Global Urine Drug Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 12. Global Urine Drug Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Urine Drug Testing Service Revenue Market Share by Region (2020-2031)
Figure 14. Global Urine Drug Testing Service Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. On-site Testing Revenue Market Share by Player in 2024
Figure 17. Laboratory-based Testing Revenue Market Share by Player in 2024
Figure 18. Global Urine Drug Testing Service Revenue Market Share by Type (2020-2031)
Figure 19. Global Urine Drug Testing Service Revenue Market Share by Application (2020-2031)
Figure 20. North America Urine Drug Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Urine Drug Testing Service Revenue (US$ Million) in 2024
Figure 22. North America Urine Drug Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Urine Drug Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Urine Drug Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Urine Drug Testing Service Revenue (US$ Million) in 2024
Figure 29. Europe Urine Drug Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Urine Drug Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 32. France Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Urine Drug Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Urine Drug Testing Service Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Urine Drug Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Urine Drug Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. India Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Urine Drug Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Urine Drug Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Urine Drug Testing Service Revenue (US$ Million) in 2024
Figure 52. Central and South America Urine Drug Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Urine Drug Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Urine Drug Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Urine Drug Testing Service Revenue (US$ Million) in 2024
Figure 58. South America Urine Drug Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Urine Drug Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Urine Drug Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. Urine Drug Testing Service Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Urine Drug Testing Service in 2031?
The global market size of Urine Drug Testing Service in 2031 was 2829 Million USD.
What is the annual compound growth rate of the global Urine Drug Testing Service market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Urine Drug Testing Service in 2025?
Which companies rank high in the global Urine Drug Testing Service market?
Related Reports
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 132
USD 4900.00
(Single User License)
Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urine Drug Testing Service market size was US$ 2157 million in 2025 and is forecast to reach a readjusted size of US$ 2946 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 98
USD 4250.00
(Single User License)
Global Urine Drug Testing Service Market Research Report 2026
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 118
USD 2900.00
(Single User License)
Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urine Drug Testing Service was estimated to be worth US$ 2157 million in 2025 and is projected to reach US$ 2946 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 112
USD 3950.00
(Single User License)
Global Urine Drug Testing Service Market Research Report 2025
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-08-13
Pages: 87
USD 2900.00
(Single User License)
Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 116
USD 3950.00
(Single User License)
Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 98
USD 4250.00
(Single User License)
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 132
USD 4900.00 (Single User License)Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urine Drug Testing Service market size was US$ 2157 million in 2025 and is forecast to reach a readjusted size of US$ 2946 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 98
USD 4250.00 (Single User License)Global Urine Drug Testing Service Market Research Report 2026
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 118
USD 2900.00 (Single User License)Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urine Drug Testing Service was estimated to be worth US$ 2157 million in 2025 and is projected to reach US$ 2946 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 112
USD 3950.00 (Single User License)Global Urine Drug Testing Service Market Research Report 2025
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-08-13
Pages: 87
USD 2900.00 (Single User License)Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 116
USD 3950.00 (Single User License)Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 98
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now